Ireland has temporarily halted its use of the Oxford/AstraZeneca jab after some reports of blood clots in vaccinated people.
The move came after a review from the Norwegian Medicines Agency showed four new cases of “serious blood clotting in adults” had occurred after the jab.
Ireland’s Deputy Chief Medical Officer, Dr. Ronan Glynn, recommended: “the administration of COVID-19 Vaccine AstraZeneca be temporarily deferred from this morning, Sunday 14th March”.
He added: “It has not been concluded that there is any link between the COVID-19 Vaccine AstraZeneca and these cases.
“However, acting on the precautionary principle, and pending receipt of further information, the NIAC has recommended the temporary deferral of the COVID-19 vaccine AstraZeneca vaccination programme in Ireland.
“The NIAC is due to meet again this morning. A further statement will follow thereafter.”
The latest figures show that as of Thursday the overwhelming majority of vaccines given out in Ireland are produced by Pfizer. A total of 589,512 jabs have been administered, of which 452,927 were Pfizer jabs, and 117,507 were AstraZeneca.